{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:49:33Z","timestamp":1787647773834,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1136\/ijgc-2022-003506","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T11:00:10Z","timestamp":1654686010000},"page":"913-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The utility of physical examination in ovarian cancer recurrence detection: a retrospective analysis informing virtual surveillance care"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4339-8779","authenticated-orcid":false,"given":"Monica J","family":"Janke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6657-5016","authenticated-orcid":false,"given":"Alli M","family":"Straubhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitanshu","family":"Uppal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2022-003506_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2017.03.022","article-title":"An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations","volume":"146","author":"Salani","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003506_bb0015","unstructured":"National Comprehensive Cancer Network (NCCN) . NCCN Guidelines: Ovarian cancer\/fallopian tube cancer\/primary peritoneal cancer. Available: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1453 [Accessed 27 Oct 2021]."},{"key":"10.1136\/ijgc-2022-003506_bb0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ygyno.2010.10.028","article-title":"Ovarian cancer patient surveillance after curative-intent initial treatment","volume":"120","author":"Harmandayan","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003506_bb0025","doi-asserted-by":"crossref","first-page":"e19045","DOI":"10.2196\/19045","article-title":"Telehealth as a bright spot of the COVID-19 pandemic: recommendations from the virtual frontlines (\"Frontweb\")","volume":"6","author":"Olayiwola","year":"2020","journal-title":"JMIR Public Health Surveill"},{"key":"10.1136\/ijgc-2022-003506_bb0030","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1002\/onco.13676","article-title":"Rapid implementation of telemedicine during the COVID-19 pandemic: perspectives and preferences of patients with cancer","volume":"26","author":"Hasson","year":"2021","journal-title":"Oncologist"},{"key":"10.1136\/ijgc-2022-003506_bb0035","doi-asserted-by":"crossref","DOI":"10.2196\/20786","article-title":"Patient satisfaction with telemedicine during the COVID-19 pandemic: retrospective cohort study","volume":"22","author":"Ramaswamy","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1136\/ijgc-2022-003506_bb0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ijgc-2020-001419","article-title":"COVID-19 global pandemic: options for management of gynecologic cancers","volume":"30","author":"Ramirez","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-003506_bb0045","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/ijgc-2020-001942","article-title":"Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)","volume":"31","author":"Mancebo","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-003506_bb0050","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/IGC.0b013e3181f63a28","article-title":"What surveillance plan should be advised for patients in remission after completion of first-line therapy for advanced ovarian cancer?","volume":"20","author":"Rustin","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-003506_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/jca.7810","article-title":"Current approaches and challenges in managing and monitoring treatment response in ovarian cancer","volume":"5","author":"Marcus","year":"2014","journal-title":"J Cancer"},{"key":"10.1136\/ijgc-2022-003506_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ygyno.2006.02.005","article-title":"Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levels","volume":"103","author":"Menczer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003506_bb0065","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ygyno.2008.04.030","article-title":"The role of regular physical examination in the detection of ovarian cancer recurrence","volume":"110","author":"Chan","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003506_bb0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/ijgc-2021-002885","article-title":"Ovarian cancer recurrence detection may not require in-person physical examination: an MSK team ovary study","volume":"32","author":"Feinberg","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-003506_bb0075","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.7314\/APJCP.2013.14.12.7193","article-title":"Detection of recurrence in a surveillance program for epithelial ovarian cancer","volume":"14","author":"Suprasert","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1136\/ijgc-2022-003506_bb0080","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/sj.bjc.6605963","article-title":"The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review","volume":"103","author":"Rettenmaier","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2022-003506_bb0085","article-title":"The role of asymptomatic screening in the detection of recurrent ovarian cancer","volume":"33","author":"Richardson","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2022-003506_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1525-1438.2007.00826.x","article-title":"Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature","volume":"17","author":"Gadducci","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2022-003506_bb0095","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/00001888-200311000-00019","article-title":"Pelvic examination training for interns: a randomized controlled trial","volume":"78","author":"Herbers","year":"2003","journal-title":"Acad Med"},{"key":"10.1136\/ijgc-2022-003506_bb0100","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/1471-0528.12289","article-title":"Simulation training for breast and pelvic physical examination: a systematic review and meta-analysis","volume":"120","author":"Dilaveri","year":"2013","journal-title":"BJOG"},{"key":"10.1136\/ijgc-2022-003506_bb0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ygyno.2013.09.017","article-title":"Evaluation of the cost of CA-125 measurement, physical exam, and imaging in the diagnosis of recurrent ovarian cancer","volume":"131","author":"Armstrong","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003506_bb0110","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ygyno.2021.01.040","article-title":"Crowdsourcing to measure financial toxicity in gynecologic oncology","volume":"161","author":"Esselen","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003506_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2019.04.003","article-title":"Financial toxicity in gynecologic oncology","volume":"154","author":"Bouberhan","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003506_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pon.5763","article-title":"Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors","volume":"31","author":"Benedict","year":"2022","journal-title":"Psychooncology"},{"key":"10.1136\/ijgc-2022-003506_bb0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ygyno.2021.04.037","article-title":"Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum","volume":"162","author":"McAlarnen","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2022-003506_bb0130","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1002\/onco.13568","article-title":"Providing supportive and palliative care using telemedicine for patients with advanced cancer during the COVID-19 pandemic in Mexico","volume":"26","author":"Ch\u00e1varri-Guerra","year":"2021","journal-title":"Oncologist"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24007813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24007813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2022-003506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:27:14Z","timestamp":1753234034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24007813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1048891X24007813"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2022-003506","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The utility of physical examination in ovarian cancer recurrence detection: a retrospective analysis informing virtual surveillance care","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2022-003506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}